Unlocking the value of R&D - Managing the risks

被引：0

作者：

Pass, D ^{[1
]}

Postle, M ^{[1
]}

机构：

[1] Cambridge Pharma Consultancy, Cambridge CB5 8AB, England

来源：

BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 2002年 / 15卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

How does big pharma look at your biotech company as a potential partner? This often depends on how it looks at its own research and development investments and how it presents them to shareholders. This insider's look at biotech-pharma collaboration shows you the other side of the equation.

引用

页码：67 / 71

页数：5

共 50 条

[1] Unlocking R&D tax relief
Reid, Andrew
[J]. Engineer, 2010, APRIL
[2] Managing the R&D staff
Herzog, R
[J]. DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 488 - 493
[3] Managing R&D in China
von Zedtwitz, M
[J]. R & D MANAGEMENT, 2004, 34 (04) : 341 - 343
[4] Managing risks in technological R&D projects with Probability-Impact AHPSort
Lopez, Cristina
Moheimani, Arash
Ishizaka, Alessio
[J]. ANNALS OF OPERATIONS RESEARCH, 2024, : 1285 - 1320
[5] The Value Of R&D
Baum, Rudy M.
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (22) : 5 - 5
[6] Unlocking r&d potential with equipment expertise
Van Kampen, Andreas
Broker, Thomas
Hani, Carola
[J]. Manufacturing Chemist, 2019, 90 (09): : 34 - 35
[7] Value-Creating Potentials and Attendant Risks for R&D Portfolios
Lee, Hwey-chyi
Ouyang, Lishu
[J]. 2008 IEEE INTERNATIONAL CONFERENCE ON MANAGEMENT OF INNOVATION AND TECHNOLOGY, VOLS 1-3, 2008, : 1199 - +
[8] Managing the appropriability of R&D collaboration
Henttonen, Kaisa
Hurmelinna-Laukkanen, Pia
Ritala, Paavo
[J]. R & D MANAGEMENT, 2016, 46 : 145 - 158
[9] Managing innovative R&D teams
Thamhain, HJ
[J]. R & D MANAGEMENT, 2003, 33 (03) : 297 - 311
[10] Managing people in R&D - Editorial
不详
[J]. R & D MANAGEMENT, 2005, 35 (05) : 471 - 471

← 1 2 3 4 5 →